Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 138.50
+5.50 (4.14%)
Sep 30, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 16.11 billion as of September 29, 2026. Its market cap has increased by 32.17% in one year.
Market Cap
16.11B
Enterprise Value
14.75B
Revenue
42.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
138.50
ChartMarket Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 16.11B, an increase of 81.68%. That is a compound annual growth rate of 6.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 16.11B | 52.58% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 25.68B |
| Oneness Biotech | 21.91B |
| Sunmax Biotechnology | 21.76B |
| Medigen Vaccine Biologics | 20.02B |
| TaiMed Biologics | 17.21B |
| Ever Supreme Bio Technology | 16.27B |
| ACRO Biomedical | 15.99B |
| EirGenix | 15.35B |